Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Filippa Pettersson, Sonia V del Rincon & Wilson H Miller$suffix/text()$suffix/text(). (2014) Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond. Expert Opinion on Therapeutic Targets 18:9, pages 1035-1048.
Read now
Read now
Argun Akcakanat, David S Hong & Funda Meric-Bernstam. (2014) Targeting translation initiation in breast cancer. Translation 2:1.
Read now
Read now
Articles from other publishers (58)
Vladimir Mulens-Arias, Yadileiny Portilla, Sonia Pérez-Yagüe, Raquel Ferreras-Martín, M. Elena Martín, Victor M. González & Domingo F. Barber. (2023) An electrostatically conjugated-functional MNK1 aptamer reverts the intrinsic antitumor effect of polyethyleneimine-coated iron oxide nanoparticles in vivo in a human triple-negative cancer xenograft. Cancer Nanotechnology 14:1.
Crossref
Crossref
Shuo Li, Jia-shu Chen, Xiangqian Li, Xiaoyi bai & Dayong Shi. (2023) MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation. European Journal of Medicinal Chemistry 260, pages 115781.
Crossref
Crossref
Ann Fernandez, Paige J. Monsen, Leonidas C. Platanias & Gary E. Schiltz. (2023) Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer. RSC Medicinal Chemistry 14:6, pages 1060-1087.
Crossref
Crossref
Rakesh Sahu, Kamal Shah, Yash Gautam & Kaushilya Sahu. (2023) Pyrazine Moiety: Recent Developments in Cancer Treatment. Current Organic Chemistry 27:10, pages 821-843.
Crossref
Crossref
Rebeca Carrión-Marchante, Celia Pinto-Díez, José Ignacio Klett-Mingo, Esther Palacios, Miriam Barragán-Usero, M. Isabel Pérez-Morgado, Manuel Pascual-Mellado, Sonia Alcalá, Laura Ruiz-Cañas, Bruno SainzJr.Jr., Víctor M. González & M. Elena Martín. (2023) An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 15:4, pages 1273.
Crossref
Crossref
C. Pinto-Díez, R. Ferreras-Martín, R. Carrión-Marchante, J.I. Klett-Mingo, M. García-Hernández, M.I. Pérez-Morgado, S. Sacristán, M. Barragán, M. Seijo-Vila, I. Tundidor, S. Blasco-Benito, E. Pérez-Gómez, I. Gómez-Pinto, C. Sánchez, C. González, V.M. González & M.E. Martín. (2022) An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer. Molecular Therapy - Nucleic Acids 30, pages 553-568.
Crossref
Crossref
Roni H. G. Wright, Viviana Vastolo, Javier Quilez Oliete, José Carbonell-Caballero & Miguel Beato. (2022) Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone. Frontiers in Endocrinology 13.
Crossref
Crossref
Sahar Jafari Nivlouei, Madjid Soltani, Ebrahim Shirani, Mohammad Reza Salimpour, Rui Travasso & João Carvalho. (2022) A multiscale cell‐based model of tumor growth for chemotherapy assessment and tumor‐targeted therapy through a 3D computational approach. Cell Proliferation 55:3.
Crossref
Crossref
Wenzhu Zhang, Linlin Liu, Shengdi Zhao, Liang Chen, Yuxian Wei, Wenlin Chen & Fei Ge. (2022) Research progress on RNA‑binding proteins in breast cancer (Review). Oncology Letters 23:4.
Crossref
Crossref
Andrea Muñoz-Ayala, Brenda Chimal-Vega & Victor García-González. 2022. Disorders of Protein Synthesis. Disorders of Protein Synthesis
111
141
.
Sahar Jafari Nivlouei, M. Soltani, João Carvalho, Rui Travasso, Mohammad Reza Salimpour & Ebrahim Shirani. (2021) Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy. PLOS Computational Biology 17:6, pages e1009081.
Crossref
Crossref
Liwen Zhang, Lu Han, Yubei Huang, Ziwei Feng, Xin Wang, Haixin Li, Fangfang Song, Luyang Liu, Junxian Li, Hong Zheng, Peishan Wang, Fengju Song & Kexin Chen. (2021) SNPs within microRNA binding sites and the prognosis of breast cancer. Aging 13:5, pages 7465-7480.
Crossref
Crossref
Joshua D. Mannheimer, Ashok Prasad & Daniel L. Gustafson. (2021) Predicting chemosensitivity using drug perturbed gene dynamics. BMC Bioinformatics 22:1.
Crossref
Crossref
Shi-Long Jiang, Jun-Luan Mo, Ji Peng, Lin Lei, Ji-Ye Yin, Hong-Hao Zhou, Zhao-Qian Liu & Wen-Xu Hong. (2021) Targeting translation regulators improves cancer therapy. Genomics 113:1, pages 1247-1256.
Crossref
Crossref
Yulin Xu, Shichong Liao, Lijun Wang, Yuan Wang, Wen Wei, Ke Su, Yi Tu & Shan Zhu. (2020) Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin. Cancer Chemotherapy and Pharmacology 87:1, pages 85-93.
Crossref
Crossref
Xiaotong Yang, Wu Zhong & Ruifeng Cao. (2020) Phosphorylation of the mRNA cap-binding protein eIF4E and cancer. Cellular Signalling 73, pages 109689.
Crossref
Crossref
Sathyen A. Prabhu, Omar Moussa, Wilson H. MillerJr.Jr. & Sonia V. del Rincón. (2020) The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma. International Journal of Molecular Sciences 21:11, pages 4055.
Crossref
Crossref
Asiya Batool, Sheikh Tahir Majeed, Sabreena Aashaq, Rabiya Majeed & Khurshid Iqbal Andrabi. (2020) Eukaryotic Initiation Factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly. Biochemical and Biophysical Research Communications 527:2, pages 489-495.
Crossref
Crossref
Celia Pinto-Díez, Raquel Ferreras-Martín, Rebeca Carrión-Marchante, Víctor M. González & María Elena Martín. (2020) Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer. International Journal of Molecular Sciences 21:8, pages 2967.
Crossref
Crossref
Angelina Pranteda, Valentina Piastra, Lorenzo Stramucci, Deborah Fratantonio & Gianluca Bossi. (2020) The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments. International Journal of Molecular Sciences 21:8, pages 2773.
Crossref
Crossref
Asiya Batool, Sheikh Tahir Majeed, Sabreena Aashaq, Rabiya Majeed, Nadiem Nazir Bhat & Khurshid Iqbal Andrabi. (2019) Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1. Molecular and Cellular Biochemistry 465:1-2, pages 13-26.
Crossref
Crossref
Lijun Wang, Chuanlong Guo, Xiuxue Li, Xuemin Yu, Xiangqian Li, Kuo Xu, Bo Jiang, Xiaoling Jia, Chao Li & Dayong Shi. (2019) Design, synthesis and biological evaluation of bromophenol-thiazolylhydrazone hybrids inhibiting the interaction of translation initiation factors eIF4E/eIF4G as multifunctional agents for cancer treatment. European Journal of Medicinal Chemistry 177, pages 153-170.
Crossref
Crossref
Qianyu Guo, Vivian Z. Li, Jessica N. Nichol, Fan Huang, William Yang, Samuel E.J. Preston, Zahra Talat, Hanne Lefrère, Henry Yu, Guihua Zhang, Mark Basik, Christophe Gonçalves, Yao Zhan, Dany Plourde, Jie Su, Jose Torres, Maud Marques, Sara Al Habyan, Krikor Bijian, Frédéric Amant, Michael Witcher, Fariba Behbod, Luke McCaffrey, Moulay Alaoui-Jamali, Nadia V. Giannakopoulos, Muriel Brackstone, Lynne-Marie Postovit, Sonia V. del Rincón & Wilson H. MillerJrJr. (2019)
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma
In Situ
. Cancer Research 79:7, pages 1646-1657.
Crossref
Crossref
Xinrui Yuan, Hanshu Wu, Hong Bu, Peiyuan Zheng, Jinpei Zhou & Huibin Zhang. (2019) Design, synthesis and biological evaluation of pyridone–aminal derivatives as MNK1/2 inhibitors. Bioorganic & Medicinal Chemistry 27:7, pages 1211-1225.
Crossref
Crossref
Senthilmurugan Ramalingam, Vidya Ramamurthy, Lalji Gediya, Francis Murigi, Puranik Purushottamachar, Weiliang Huang, Eun Choi, Yuji Zhang, Tadas Vasaitis, Maureen Kane, Rena Lapidus & Vincent Njar. (2019) The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis. Cancers 11:3, pages 299.
Crossref
Crossref
Asiya Batool, Sheikh Tahir Majeed, Sabreena Aashaq, Rabiya Majeed, Ghazia Shah, Nadiem Nazir & Khurshid Iqbal Andrabi. (2019) Eukaryotic Initiation Factor 4E (eIF4E) sequestration mediates 4E-BP1 response to rapamycin. International Journal of Biological Macromolecules 125, pages 651-659.
Crossref
Crossref
Xinrui Yuan, Hanshu Wu, Hong Bu, Jinpei Zhou & Huibin Zhang. (2019) Targeting the immunity protein kinases for immuno-oncology. European Journal of Medicinal Chemistry 163, pages 413-427.
Crossref
Crossref
Changlei Xi, Ling Wang, Jie Yu, Hui Ye, Longlei Cao & Zhilin Gong. (2018) Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer. Biochemical and Biophysical Research Communications 503:4, pages 2286-2292.
Crossref
Crossref
Haiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, Shi Hua Ang, Eldwin Sum Wai Tan, Duraiswamy Athisayamani Jeyaraj, Yoon Sheng Yeap, Boping Liu, Esther Hq Ong, Joma Kanikadu Joy, John Liang Kuan Wee, Perlyn Kwek, Priya Retna, Nurul Dinie, Thuy Thi Hanh Nguyen, Shi Jing Tai, Vithya Manoharan, Vishal Pendharkar, Choon Bing Low, Yun Shan Chew, Susmitha Vuddagiri, Kanda Sangthongpitag, Meng Ling Choong, May Ann Lee, Srinivasaraghavan Kannan, Chandra S. Verma, Anders Poulsen, Sharon Lim, Charles Chuah, Tiong Sin Ong, Jeffrey Hill, Alex Matter & Kassoum Nacro. (2018) Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia. Journal of Medicinal Chemistry 61:10, pages 4348-4369.
Crossref
Crossref
Siegfried H. Reich, Paul A. Sprengeler, Gary G. Chiang, James R. Appleman, Joan Chen, Jeff Clarine, Boreth Eam, Justin T. Ernst, Qing Han, Vikas K. Goel, Edward Z. R. Han, Vera Huang, Ivy N. J. Hung, Adrianna Jemison, Katti A. Jessen, Jolene Molter, Douglas Murphy, Melissa Neal, Gregory S. Parker, Michael Shaghafi, Samuel Sperry, Jocelyn Staunton, Craig R. Stumpf, Peggy A. Thompson, Chinh Tran, Stephen E. Webber, Christopher J. Wegerski, Hong Zheng & Kevin R. Webster. (2018) Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition. Journal of Medicinal Chemistry 61:8, pages 3516-3540.
Crossref
Crossref
Celia Pinto-Díez, Eva M. García-Recio, M. Isabel Pérez-Morgado, Marta García-Hernández, Lara Sanz-Criado, Silvia Sacristán, M. Val Toledo-Lobo, Belén Pérez-Mies, Isabel Esteban-Rodríguez, Alejandro Pascual, Mercedes Garcia-Villanueva, Noelia Martínez-Jañez, Víctor M. González & M. Elena Martín. (2018) Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer. Oncotarget 9:17, pages 13501-13516.
Crossref
Crossref
Phillip A. Geter, Amanda W. Ernlund, Sofia Bakogianni, Amandine Alard, Rezina Arju, Shah Giashuddin, Abhilash Gadi, Jacqueline Bromberg & Robert J. Schneider. (2017) Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming. Genes & Development 31:22, pages 2235-2249.
Crossref
Crossref
M.D. Berger, S. Stintzing, V. Heinemann, D. Yang, S. Cao, Y. Sunakawa, Y. Ning, S. Matsusaka, S. Okazaki, Y. Miyamoto, M. Suenaga, M. Schirripa, S. Soni, W. Zhang, A. Falcone, F. Loupakis & H.-J. Lenz. (2017) Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials. Annals of Oncology 28:11, pages 2780-2785.
Crossref
Crossref
Yao Zhan, Jun Guo, William Yang, Christophe Goncalves, Tomasz Rzymski, Agnieszka Dreas, Eliza Żyłkiewicz, Maciej Mikulski, Krzysztof Brzózka, Aniela Golas, Yan Kong, Meng Ma, Fan Huang, Bonnie Huor, Qianyu Guo, Sabrina Daniela da Silva, Jose Torres, Yutian Cai, Ivan Topisirovic, Jie Su, Krikor Bijian, Moulay A. Alaoui-Jamali, Sidong Huang, Fabrice Journe, Ghanem E. Ghanem, Wilson H. MillerJr.Jr. & Sonia V. del Rincón. (2017) MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. Journal of Clinical Investigation 127:11, pages 4179-4192.
Crossref
Crossref
Zhihua Guo, Guilin Peng, Ermao Li, Shaoyan Xi, Yu Zhang, Yong Li, Xiaodong Lin, Guangqiu Li, Qinian Wu & Jianxing He. (2017) MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer. Scientific Reports 7:1.
Crossref
Crossref
S. Hou, P. Du, P. Wang, C. Wang, P. Liu & H. Liu. (2017) Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer. Clinical and Translational Oncology 19:9, pages 1107-1116.
Crossref
Crossref
Muhammad Umar Ali, Muhammad Saif Ur Rahman, Zhenyu Jia & Cao Jiang. (2017) Eukaryotic translation initiation factors and cancer. Tumor Biology 39:6, pages 101042831770980.
Crossref
Crossref
Zhiqiang Li, Yang Sun, Miao Qu, Hongxing Wan, Fang Cai & Peng Zhang. (2016) Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy. Oncotarget 8:2, pages 2906-2915.
Crossref
Crossref
Rebecca A Millican-Slater, Craig D Sayers, Andrew M Hanby & Thomas A Hughes. (2016) Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer. British Journal of Cancer 115:3, pages 339-345.
Crossref
Crossref
K-S Hsu, B-J Guan, X Cheng, D Guan, M Lam, M Hatzoglou & H-Y Kao. (2015) Translational control of PML contributes to TNFα-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs. Cell Death & Differentiation 23:3, pages 469-483.
Crossref
Crossref
Eva M García-Recio, Celia Pinto-Díez, M Isabel Pérez-Morgado, Marta García-Hernández, Gerónimo Fernández, M Elena Martín & Víctor M González. (2016) Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells. Molecular Therapy - Nucleic Acids 5, pages e275.
Crossref
Crossref
Chunwan Lu, Levi Makala, Daqing Wu & Yafei Cai. (2016) Targeting translation: eIF4E as an emerging anticancer drug target. Expert Reviews in Molecular Medicine 18.
Crossref
Crossref
Jaroslaw Cendrowski, Víctor J Sánchez-Arévalo Lobo, Matthias Sendler, Antonio Salas, Jens-Peter Kühn, Xavier Molero, Rikiro Fukunaga, Julia Mayerle, Markus M Lerch & Francisco X Real. (2015) Mnk1 is a novel acinar cell-specific kinase required for exocrine pancreatic secretion and response to pancreatitis in mice. Gut 64:6, pages 937-947.
Crossref
Crossref
Alba Martínez, Marta Sesé, Javier Hernandez Losa, Nathaniel Robichaud, Nahum Sonenberg, Trond Aasen & Santiago Ramón y Cajal. (2015) Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches. PLOS ONE 10:4, pages e0123352.
Crossref
Crossref
Vidya P. Ramamurthy, Senthilmurugan Ramalingam, Lalji Gediya, Andrew K. Kwegyir-Afful & Vincent C.O. Njar. (2014) Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines. Oncotarget 6:5, pages 3195-3210.
Crossref
Crossref
Theodosia Teo, Mingfeng Yu, Yuchao Yang, Todd Gillam, Frankie Lam, Matthew J. Sykes & Shudong Wang. (2015) Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells. Cancer Letters 357:2, pages 612-623.
Crossref
Crossref
Frankie Lam, Abdullahi Y. Abbas, Hao Shao, Theodosia Teo, Julian Adams, Peng Li, Tracey D. Bradshaw, Peter M. Fischer, Elisabeth Walsby, Chris Pepper, Yi Chen, Jian Ding & Shudong Wang. (2014) Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73. Oncotarget 5:17, pages 7691-7704.
Crossref
Crossref
Sarah Diab, Theodosia Teo, Malika Kumarasiri, Peng Li, Mingfeng Yu, Frankie Lam, Sunita K. C. Basnet, Matthew J. Sykes, Hugo Albrecht, Robert Milne & Shudong Wang. (2014)
Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3
H
)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
. ChemMedChem 9:5, pages 962-972.
Crossref
Crossref
Sarah Diab, Malika Kumarasiri, Mingfeng Yu, Theodosia Teo, Christopher Proud, Robert Milne & Shudong Wang. (2014) MAP Kinase-Interacting Kinases—Emerging Targets against Cancer. Chemistry & Biology 21:4, pages 441-452.
Crossref
Crossref
Jun Zheng, Jiao Li, Lina Xu, Guiyuan Xie, Qiuyuan Wen, Jiadi Luo, Duo Li, Donghai Huang & Songqing Fan. (2014) Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma. PLoS ONE 9:2, pages e89220.
Crossref
Crossref
Armen Parsyan, Ana Maria Gonzalez-Angulo, Dimitrios Zardavas, Martine Piccart & Sarkis Meterissian. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
513
555
.
Luc Furic, Emma Beardsley & Ivan Topisirovic. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
363
374
.
Sharon LimTzuen Yih SawMin ZhangMatthew R. JanesKassoum NacroJeffrey HillAn Qi LimChia-Tien ChangDavid A. FrumanDavid A. RizzieriSoo Yong Tan, Hung FanCharles T. H. ChuahS. Tiong Ong. (2013) Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proceedings of the National Academy of Sciences 110:25.
Crossref
Crossref
SONG LIANG, RENHUA GUO, ZHIHONG ZHANG, DONGXIAO LIU, HAO XU, ZEKUAN XU, XUERONG WANG & LI YANG. (2013) Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth. Oncology Reports 29:6, pages 2422-2430.
Crossref
Crossref
Martin CarrollKatherine L.B. Borden. (2013) The Oncogene eIF4E: Using Biochemical Insights to Target Cancer. Journal of Interferon & Cytokine Research 33:5, pages 227-238.
Crossref
Crossref
H Bradley Shaffer, Patrick Minx, Daniel E Warren, Andrew M Shedlock, Robert C Thomson, Nicole Valenzuela, John Abramyan, Chris T Amemiya, Daleen Badenhorst, Kyle K Biggar, Glen M Borchert, Christopher W Botka, Rachel M Bowden, Edward L Braun, Anne M Bronikowski, Benoit G Bruneau, Leslie T Buck, Blanche Capel, Todd A Castoe, Mike Czerwinski, Kim D Delehaunty, Scott V Edwards, Catrina C Fronick, Matthew K Fujita, Lucinda Fulton, Tina A Graves, Richard E Green, Wilfried Haerty, Ramkumar Hariharan, Omar Hernandez, LaDeana W Hillier, Alisha K Holloway, Daniel Janes, Fredric J Janzen, Cyriac Kandoth, Lesheng Kong, AP de Koning, Yang Li, Robert Literman, Suzanne E McGaugh, Lindsey Mork, Michelle O'Laughlin, Ryan T Paitz, David D Pollock, Chris P Ponting, Srihari Radhakrishnan, Brian J Raney, Joy M Richman, John St John, Tonia Schwartz, Arun Sethuraman, Phillip Q Spinks, Kenneth B Storey, Nay Thane, Tomas Vinar, Laura M Zimmerman, Wesley C Warren, Elaine R Mardis & Richard K Wilson. (2013) The western painted turtle genome, a model for the evolution of extreme physiological adaptations in a slowly evolving lineage. Genome Biology 14:3, pages R28.
Crossref
Crossref
Shirong Li, Jing Fu & Suzanne Lentzsch. 2013. Genetic and Molecular Epidemiology of Multiple Myeloma. Genetic and Molecular Epidemiology of Multiple Myeloma
43
57
.
Sonali Joshi, Bhumika Sharma, Surinder Kaur, Beata Majchrzak, Takeshi Ueda, Rikiro Fukunaga, Amit K. Verma, Eleanor N. Fish & Leonidas C. Platanias. (2011) Essential Role for Mnk Kinases in Type II Interferon (IFNγ) Signaling and Its Suppressive Effects on Normal Hematopoiesis. Journal of Biological Chemistry 286:8, pages 6017-6026.
Crossref
Crossref